Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut
Pfizer’s stock gains after the drugmaker boosted its full-year profit outlook.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
